# CRISPR’s Hidden Value Amid Stock Dip

Page: https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/crispr-s-hidden-value-amid-stock-dip
Text version: https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/crispr-s-hidden-value-amid-stock-dip.md
Podcast: [Business News Today | 2 Min News | The Daily News Now!](https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192)
Published: 2026-06-08T18:06:27+00:00
Episode link: https://api.fastcast.ai/audio/2e3af031-a26d-4ab1-986c-4666890c99ed.mp3
Audio file: https://api.fastcast.ai/audio/2e3af031-a26d-4ab1-986c-4666890c99ed.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/crispr-s-hidden-value-amid-stock-dip
Duration seconds: 141

## Resource

CRISPR Therapeutics holds a blockbuster gene-editing therapy, Casgevy, approved for blood disorders and already treating 500+ patients at a $2.2M price tag—yet its stock trades 40% below analyst estimates. Despite Nobel-winning tech and a pipeline targeting diabetes, heart disease, and more, investors hesitate due to high costs, delayed revenue recognition, and profit-sharing with Vertex. A recent $600M raise risks dilution, but the long-term upside is massive: analysts see a much higher price target, and the company remains a prime acquisition target as the gene-editing field surges. It’s a high-risk, high-reward biotech bet—waiting for the market to believe the science will soon pay off. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/d36ccb29d00f5984

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/crispr-s-hidden-value-amid-stock-dip/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/crispr-s-hidden-value-amid-stock-dip.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.